leisure time -WSS

leisure time

author：knowledge 2025-09-06 04:41:46 - browse：15

Duchenne muscular dystrophy Histopathology — Duchenne muscular dystrophy histopathology. Dr. Edwin P. Ewing, Jr./CDC

Japanese drugmaker Nippon Shinyaku said on Monday that its Duchenne muscular dystrophy drug, Viltepso, part of a controversial class of treatments for the rare disease, had failed to reach its primary endpoint in a placebo-controlled confirmatory trial.

Children who received the drug could stand up faster from the floor at the end of the study, but so could children who received a placebo. There was no statistically significant difference between the groups.

Although Nippon did not release detailed data, the failure is notable because Viltepso belongs to a contentious class of drugs called exon-skippers. Duchenne is caused by mutations in a muscle-supporting gene called dystrophin. These drugs are designed to increase the amount of dystrophin protein that patients with specific mutations produce. But the drugs only lead to slight increases in protein levels, and their clinical benefits have never been proven in a large, placebo-controlled study.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Victims of gun violence feel impacts long after bullet wound

Wikipedia

WSS

A controversial new treatment promises to make little people taller

Study links childhood stress with decline in older age

Extreme heat events are a public health emergency

Group behind ProMed defends move to subscription

Free speech concerns arise in wake of journal editor Eisen's firing

Removing probiotics from the NICU could threaten preemies' health

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Medical leaders decry Supreme Court decision on affirmative action

How to ethically and practically extend health care to all

Activists slam private health insurers over coverage restrictions

Just how powerful is the placebo effect?

Hepatitis C has a cure — but many Americans still lack access to it

It costs an awful lot of money to give away a kidney

Activists slam private health insurers over coverage restrictions

Medicare solvency divides Republicans at the presidential debate

Duchenne breakthrough therapy leaves behind pioneering families

2 officers injured in shooting in Orlando, police say

leisure time

Excited delirium, Elijah McClain, and emergency physicians

It costs an awful lot of money to give away a kidney

A clever new way to fix Medicaid and graduate medical education

How I helped Pfizer think through the ethics of Viagra

Group behind ProMed defends move to subscription

H.R. 3 is the wrong path to lower drug costs

hotspot

entertainment

Wikipedia

focus